More Mixed Results for Remdesivir: Moderate COVID-19 Patients More Mixed Results for Remdesivir: Moderate COVID-19 Patients

The drug ' s manufacturer is pushing the FDA to expand the emergency use authorization to full approval for all hospitalized with COVID-19. But some experts say there are too many unanswered questions.Medscape Medical News
Source: Medscape Internal Medicine Headlines - Category: Internal Medicine Tags: Infectious Diseases News Source Type: news